Tsujimoto G, Honda K, Hoffman B B, Hashimoto K
Circ Res. 1987 Jul;61(1):86-98. doi: 10.1161/01.res.61.1.86.
Prolonged stimulation of tissues by adrenergic agonists may lead to diminished responsiveness of the tissues to subsequent activation by catecholamines; this phenomenon has been termed desensitization or tachyphylaxis. We have examined the in vivo consequences of prolonged stimulation of vascular alpha-adrenergic receptors in rats harboring pheochromocytoma, a tumor that secretes catecholamines. In both early (3-4 weeks after implantation) and late (6-7 weeks after implantation) stages of tumor development, New England Deaconess Hospital rats with transplanted pheochromocytomas developed hypertension and tachycardia and had plasma dopamine and norepinephrine concentrations markedly greater than controls. In both these stages of pheochromocytoma, pressor responses to several vasoconstrictors were examined after pithing. Rats with the tumor were found to become progressively subsensitive to alpha-adrenergic agonists. In the early phase of pheochromocytoma, loss in sensitivity was found for both alpha 1- and alpha 2-adrenergic agonists, whereas responsiveness to the nonadrenergic vasoconstrictors Arg-vasopressin and angiotensin-II was intact (homologous desensitization). However, in the later stage of pheochromocytoma, pressor responses to all these vasoconstrictive agents and also to stimulation of the complex sympathetic outflow were found to be subsensitive (heterologous desensitization). In plasma membranes prepared from mesenteric arteries of early stage tumor-bearing rats, [3H]prazosin binding sites were significantly decreased to 150 +/- 12 fmol/mg vs. 234 +/- 19 fmol/mg in controls. [3H]Yohimbine binding sites were not significantly altered. Our results show that both postjunctional alpha 1- and alpha 2-adrenergic receptor-mediated vasopressor responses can be specifically attenuated in the presence of chronically elevated endogenous catecholamine levels produced by pheochromocytoma and that each alpha-receptor subtype may be differently regulated in the development of desensitization.
肾上腺素能激动剂对组织的长期刺激可能导致组织对随后儿茶酚胺激活的反应性降低;这种现象被称为脱敏或快速耐受性。我们研究了在患有嗜铬细胞瘤(一种分泌儿茶酚胺的肿瘤)的大鼠中,长期刺激血管α-肾上腺素能受体的体内后果。在肿瘤发展的早期(植入后3 - 4周)和晚期(植入后6 - 7周),移植了嗜铬细胞瘤的新英格兰女执事医院大鼠均出现高血压和心动过速,且血浆多巴胺和去甲肾上腺素浓度明显高于对照组。在嗜铬细胞瘤的这两个阶段,在脊髓损毁后检测了对几种血管收缩剂的升压反应。发现患有肿瘤的大鼠对α-肾上腺素能激动剂逐渐变得不敏感。在嗜铬细胞瘤的早期阶段,对α1-和α2-肾上腺素能激动剂的敏感性均降低,而对非肾上腺素能血管收缩剂精氨酸加压素和血管紧张素-II的反应性保持完整(同源脱敏)。然而,在嗜铬细胞瘤的后期阶段,发现对所有这些血管收缩剂以及对复杂交感神经传出刺激的升压反应均不敏感(异源脱敏)。在早期荷瘤大鼠肠系膜动脉制备的质膜中,[3H]哌唑嗪结合位点显著减少至150±12 fmol/mg,而对照组为234±19 fmol/mg。[3H]育亨宾结合位点没有明显改变。我们的结果表明,在嗜铬细胞瘤产生的内源性儿茶酚胺水平长期升高的情况下,节后α1-和α2-肾上腺素能受体介导的升压反应均可被特异性减弱,并且每种α-受体亚型在脱敏发展过程中可能受到不同的调节。